- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03358680
Temperature and Analgesia Monitoring During Cardial Parmonary Bypass
August 4, 2018 updated by: China International Neuroscience Institution
- Investigator will apply IOC2 to reflect the depth of analgesic during hypothermia in CPB period.
- effectiveness of IOC2 monitoring for anesthetic depth versus commonly used vital sign monitoring based on factors such as blood pressure and heart rate.
- Evaluate the other sedation co-relation measurement, include BIS , IOC2 to reflected the consciousness during the operation.
- Evaluate the other hemodynamic index, include CO, SVV, CVP, PPV to reflect the circulation function , and the effect to the IOC2 and IOC1.
- Describe the trend of all the measurement. detect the variation of the index during the temperature change during the CPB.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this study,
- Investigator will apply IOC2 to reflect the depth of analgesic during hypothermia in CPB period.
- Furthermore, investigator evaluated the effectiveness of IOC2 monitoring for anesthetic depth versus commonly used vital sign monitoring based on factors such as blood pressure and heart rate.
- Evaluate the other sedation co-relation measurement, include BIS , IOC2 to reflected the consciousness during the operation.
- Evaluate the other hemodynamic index, include CO, SVV, CVP, PPV to reflect the circulation function , and the effect to the IOC2 and IOC1.
- Describe the trend of all the measurement. detect the variation of the index during the temperature change during the CPB.
Study Type
Observational
Enrollment (Actual)
39
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100053
- Xuanwu Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
the patients schedule undergoing coronary artery bypass surgery
Description
Inclusion Criteria:
- undergoing coronary artery bypass surgery
Exclusion Criteria:
- change the surgery planning during the operation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IOC2
Time Frame: 1 DAY
|
Index of consciousness 2
|
1 DAY
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BIS
Time Frame: 1 DAY
|
to monitor and compare appropriate conscious value
|
1 DAY
|
IOC1
Time Frame: 1 DAY
|
index of consciousness 1
|
1 DAY
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Zhaolong Tian, MS, Xuanwu Hospital, Beijing
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Actual)
September 1, 2017
Study Completion (Actual)
September 19, 2017
Study Registration Dates
First Submitted
November 13, 2017
First Submitted That Met QC Criteria
November 29, 2017
First Posted (Actual)
November 30, 2017
Study Record Updates
Last Update Posted (Actual)
August 7, 2018
Last Update Submitted That Met QC Criteria
August 4, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZYLX201706-11025
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on noninvasive analgesia measurement
-
Rodin Scientific LLCUniversity of Split, School of MedicineCompletedCongestive Heart FailureUnited States, Croatia
-
Hopital FochCompleted
-
University Hospital, Clermont-FerrandNot yet recruitingDyspnea | Chronic Obstructive Pulmonary Disease SevereFrance
-
The First Affiliated Hospital of Guangzhou Medical...UnknownCOPD | Hypercapnic Respiratory FailureChina
-
Universidade Federal de PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.CompletedCystic FibrosisBrazil
-
Chinese University of Hong KongRecruitingHeart FailureHong Kong
-
UPECLIN HC FM Botucatu UnespUnknownExtubation Failure | Acute Respiratory Failure Post ExtubationBrazil
-
Patri-cia Angelica de Miranda Silva NogueiraCompletedHeart Failure
-
Laval UniversityUnknownTobacco Use DisorderCanada